Pornchai Jonglertham, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 N Kansas Ave, Hastings, NE 68901 Phone: 402-460-5899 Fax: 402-460-5898 |
Debora Santos Bruno, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 N Kansas Ave, Suite 100, Hastings, NE 68901 Phone: 402-460-5899 Fax: 402-460-5619 |
Soe Min Tun, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 N Kansas Ave Ste 100, Hastings, NE 68901 Phone: 402-460-5899 Fax: 402-460-5898 |
News Archive
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.
Based on its recent analysis of the medical device integration solutions market, Frost & Sullivan recognizes CapsuleTech with the 2015 Global Frost & Sullivan Award for Customer Value Leadership. CapsuleTech's vendor-agnostic SmartLinx medical device information system (MDIS) has emerged as a valuable data management solution that ties together the medical devices across a healthcare enterprise into a unified system that not only captures and distributes patient clinical data, but also makes available operational data about the devices themselves.
If statistics compiled by the U.S. Department of Education are to be believed, in 1992 the state of Illinois had only 322 diagnosed cases of autism among school children. In 2003, according to the same statistical source, Illinois had more than 6,000 children diagnosed as autistic.
Leicester will join the likes of Copenhagen, Mexico City, Rome and Shanghai in becoming part of the Cities Changing Diabetes program to tackle the dramatic rise of type 2 diabetes in urban areas.
PepsiCo, the world's second-largest food and beverage company, today announced new global goals in the areas of nutrition, the environment, and workplace practices at its investor conference here at the Legends Suite Club in Yankee Stadium.
› Verified 5 days ago